Home Influence of human haptoglobin polymorphism on oxidative stress induced by free hemoglobin on red blood cells
Article
Licensed
Unlicensed Requires Authentication

Influence of human haptoglobin polymorphism on oxidative stress induced by free hemoglobin on red blood cells

  • Papa Madièye Guéye , Nicole Glasser , Georges Férard and Jean-Marc Lessinger
Published/Copyright: May 8, 2006

Abstract

Background: An in vitro study was conducted to determine whether haptoglobin phenotypes differed in their protective effect against oxidative stress induced by extracellular hemoglobin on red blood cells.

Methods: Conjugated dienes and thiobarbituric acid-reactive substances (TBARS) were determined in human red blood cell membranes in the presence of hemoglobin and various concentrations of each type of purified haptoglobin. In addition, the release of K+ and lactate dehydrogenase from red blood cells was measured.

Results: A protective effect of haptoglobin was observed in terms of results obtained for the four parameters examined, with significant differences (p<0.001) between the three haptoglobin types; type 1-1 was the most active and type 2-2 the least active. A proportion of oxidative damage was not sensitive to haptoglobin, but to desferrioxamine (an iron chelator), indicating the participation of two actors, hemoglobin and free iron, in the oxidative stress of membrane lipids.

Conclusions: The antioxidant role of haptoglobin and the phenotype dependence were confirmed for preventing possible oxidative damage induced by free hemoglobin and iron release during its catabolism.


Corresponding author: Pr. Jean-Marc Lessinger, Institut Gilbert Laustriat, UMR 7175 CNRS, Université Louis Pasteur (Strasbourg I), Faculté de Pharmacie, 74 route du Rhin, BP 60024, 67401 Illkirch, France Phone: +33-3-88552107, Fax: +33-3-88662028,

References

1. Babior BM. Oxidizing radicals and red cells destruction. Prog Clin Biol Res 1981; 51:173–95.Search in Google Scholar

2. Advani R, Rubin E, Mohandas N, Schrier SL. Oxidative red blood cell membrane injury in the pathophysiology of severe mouse β thalassemia. Blood 1992; 79:1064–7.10.1182/blood.V79.4.1064.bloodjournal7941064Search in Google Scholar

3. Szebeni J, Winterbourn CC, Carrel RW. Oxidative interactions between haemoglobin and membrane lipid: a liposome model. Biochem J 1984; 220:685–92.10.1042/bj2200685Search in Google Scholar

4. Everse J, Hsia N. The toxicities of native and modified hemoglobins. Free Radic Biol Med 1997; 22:1075–99.10.1016/S0891-5849(96)00499-6Search in Google Scholar

5. Sadrzadeh SM, Graf E, Panter SS, Hallaway PE, Eaton JW. Hemoglobin, a biologic Fenton reagent. J Biol Chem 1984; 259:14354–6.10.1016/S0021-9258(17)42604-4Search in Google Scholar

6. Nagababu E, Rifkind JM. Heme degradation during autoxidation of oxyhemoglobin. Biochem Biophys Res Commun 2000; 273:839–45.10.1006/bbrc.2000.3025Search in Google Scholar

7. Miller YI, Altamentova SM, Shaklai N. Oxidation of low-density lipoprotein by hemoglobin stems from a heme-initiating globin radical: antioxidant role of haptoglobin. Biochemistry 1997; 36:12189–98.10.1021/bi970258aSearch in Google Scholar

8. Ursini F, Maiorino M, Sevanian A. Membrane hydroperoxides. In: Sies H, editor. Oxidative stress: oxidants and antioxidants. London: Academic Press, 1991:319–36.Search in Google Scholar

9. Giulivi C, Cadenas E. Heme protein radicals: formation, fate, and biological consequences. Free Radic Biol Med 1998; 24:269–79.10.1016/S0891-5849(97)00226-8Search in Google Scholar

10. Polonovski M, Jayle MF. Existence dans le plasma humain d'une substance activant l'action peroxydasique de l'hémoglobine. CR Soc Biol 1938; 129:457–61.Search in Google Scholar

11. Benesch RE, Ikeda S, Benesch R. Reaction of haptoglobin with hemoglobin covalently cross-linked between the αβ dimers. J Biol Chem 1976; 251:465–70.10.1016/S0021-9258(17)33902-9Search in Google Scholar

12. Lim SK, Ferraro B, Moore K, Halliwell B. Role of haptoglobin in free hemoglobin metabolism. Redox Rep 2001; 6:219–27.10.1179/135100001101536364Search in Google Scholar

13. Wassel J. Haptoglobin: function and polymorphism. Clin Lab 2000; 46:547–52.Search in Google Scholar

14. Gutteridge JM. The antioxidant activity of haptoglobin towards haemoglobin-stimulated lipid peroxidation. Biochim Biophys Acta 1987; 917:219–23.10.1016/0005-2760(87)90125-1Search in Google Scholar

15. Nishiyama T, Hanaoka K. Hemolysis in stored red blood cell concentrates: modulation by haptoglobin or ulinastatin, a protease inhibitor. Crit Care Med 2000; 129:1979–82.Search in Google Scholar

16. Bowman BH, Kurosky A. Haptoglobin: the evolutionary product of duplication, unequal crossing over, and point mutation. Adv Hum Genet 1982; 12:189–261.Search in Google Scholar

17. Dobryszycka W. Biological function of haptoglobin: new pieces to a puzzle. Eur J Clin Chem Clin Biochem 1997; 35:647–54.Search in Google Scholar

18. Langlois MR, Delanghe JR. Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem 1996; 42:1589–600.10.1093/clinchem/42.10.1589Search in Google Scholar

19. Javid J. The effect of haptoglobin polymer size on hemoglobin binding capacity. Vox Sang 1965; 10:320–5.10.1111/j.1423-0410.1965.tb01396.xSearch in Google Scholar

20. Pastewka JV, Ness AT, Peacock AC. Hemoglobin binding by isolated polymeric proteins from human haptoglobin types 2-1 and 2-2. Some suggested polymer subunit compositions. Biochim Biophys Acta 1975; 386:530–7.10.1016/0005-2795(75)90296-2Search in Google Scholar

21. Levy AP, Roguin A, Hochberg I, Herer P, Marsh S, Nakhoul FM, et al. Haptoglobin phenotype and vascular complications in patients with diabetes. N Engl J Med 2000; 343:969–70.10.1056/NEJM200009283431313Search in Google Scholar

22. Nakhoul FM, Marsh S, Hochberg I, Leibu R, Miller BP, Levy AP. Haptoglobin genotype as a risk factor for diabetic retinopathy. J Am Med Assoc 2000; 284:1244–5.10.1001/jama.284.10.1244-aSearch in Google Scholar

23. Nakhoul FM, Zoabi R, Kanter Y, Zoabi M, Skorecki K, Hochberg I, et al. Haptoglobin phenotype and diabetic nephropathy. Diabetologia 2001; 44:602–4.10.1007/s001250051666Search in Google Scholar

24. Standing S, Price CP. A kinetic method for the determination of haptoglobin as haemoglobin binding capacity. Clin Chim Acta 1976; 66:393–403.10.1016/0009-8981(76)90239-4Search in Google Scholar

25. Rademacher BE, Steele WJ. A general method for the isolation of haptoglobin 1-1, 2-1, and 2-2 from human plasma. Anal Biochem 1987; 160:119–26.10.1016/0003-2697(87)90621-XSearch in Google Scholar

26. Hanahan DJ, Ekholm JE. The preparation of red cell ghosts (membranes). In: Fleischer S, Packer L, editors. Subcellular fractions and derived membranes, part A. Methods in enzymology, vol 331. San Diego, CA: Academic Press, 1974:168–72.Search in Google Scholar

27. Melamed-Frank M, Lache O, Enav BI, Szafranek T, Levy NS, Ricklis RM, et al. Structure-function analysis of the antioxidant properties of haptoglobin. Blood 2001; 98:3693–8.10.1182/blood.V98.13.3693Search in Google Scholar PubMed

28. Guder WG, Narayanan S, Wisser H, Zawta B, editors. Samples: from the patient to the laboratory. The impact of preanalytical variables on the quality of laboratory results. Darmstadt: GIT Verlag GmbH, 1996.Search in Google Scholar

29. Tseng CF, Lin CC, Huang HY, Liu HC, Mao SJT. Antioxidant role of human haptoglobin. Proteomics 2004; 4:2221–8.10.1002/pmic.200300787Search in Google Scholar PubMed

30. Kanner J, Harel S. Initiation of membranal lipid peroxidation by activated metmyoglobin and methemoglobin. Arch Biochem Biophys 1985; 237:314–21.10.1016/0003-9861(85)90282-6Search in Google Scholar

31. Lenfant F, Lahet J, Chaillot B, Freysz M. The protective effects of lidocaine on human erythrocytes stored for seven days at 4°C. Cell Mol Biol Lett 2004; 9:301–4.Search in Google Scholar

32. Weisbach V, Riego E, Strasser E, Zingsem J, Ringwald R, Zimmermann R, et al. The in vitro quality of washed, prestorage leucocyte-depleted red blood cell concentrates. Vox Sang 2004; 87:19–26.10.1111/j.1423-0410.2004.00526.xSearch in Google Scholar

33. Luten M, Roerdinkholder SB, Bost HJ, Bosman GJ. Survival of the fittest? Survival of stored red blood cells after transfusion. Cell Mol Biol 2004; 50:197–203.Search in Google Scholar

34. Hess JR, Rugg N, Knapp AD, Gormas JF, Silberstein EB, Greenwalt TJ. Successful storage of RBCs for 10 weeks in a new additive solution. Transfusion 2001; 41:1072–3.10.1046/j.1537-2995.2001.t01-1-41081072.xSearch in Google Scholar

35. Asleh R, Guetta J, Litman SK, Lotan RM, Levy AP. Haptoglobin genotype- and diabetes-dependent differences in iron-mediated oxidative stress in vitro and in vivo. Circ Res 2005; 96:435–41.10.1161/01.RES.0000156653.05853.b9Search in Google Scholar

36. Ziouzenkova O, Asatryan L, Sevanian A. Oxidative stress resulting from hemolysis and formation of catalytically active hemoglobin: protective strategies. Int J Clin Pharmacol Ther 1999; 37:125–32.Search in Google Scholar

37. Silva MM, Madeira VM, Almeida LM, Custodio JB. Hemolysis of human erythrocytes induced by tamoxifen is related to disruption of membrane structure. Biochim Biophys Acta 2000; 1464:49–61.10.1016/S0005-2736(99)00237-0Search in Google Scholar

38. Jackson JK, Winternitz CI, Burt HM. Mechanism of hemolysis of human erythrocytes exposed to monosodium urate monohydrate crystals. Preliminary characterization of membrane pores. Biochim Biophys Acta 1996; 1282:45–52.10.1016/0005-2736(96)00006-5Search in Google Scholar

39. Amler E, Jasinska R, Drahota Z, Zborowski J. Membrane lateral pressure as a modulator of glycerol-3-phosphate dehydrogenase activity. FEBS Lett 1990; 271:165–8.10.1016/0014-5793(90)80398-3Search in Google Scholar

40. Yu BP, Suescun EA, Yang SY. Effect of age-related lipid peroxidation on membrane fluidity and phospholipase A2: modulation by dietary restriction. Mech Age Dev 1992; 65:17–33.10.1016/0047-6374(92)90123-USearch in Google Scholar

41. Jamme I, Petit E, Divoux D, Gerbi A, Maixent JM, Nouvelot A. Modulation of mouse cerebral Na+,K+-ATPase activity by oxygen free radicals. Neuroreport 1995; 7:333–7.Search in Google Scholar

42. Stanimirovic DB, Wong J, Ball R, Durkin JP. Free radical-induced endothelial membrane dysfunction at the site of blood-brain barrier: relationship between lipid peroxidation, Na,K-ATPase activity and Cr release. Neurochem Res 1995; 20:1417–27.10.1007/BF00970589Search in Google Scholar

43. Carini M, Aldini G, Bombardelli P, Morazzoni R, Facino RM. UVB-induced hemolysis of rat erythrocytes: protective effect of procyanidins from grape seeds. Life Sci 2000; 67:1799–814.10.1016/S0024-3205(00)00771-2Search in Google Scholar

44. Colado Simao AN, Suzukawa AA, Casado MF, Oliviera RD, Guarnier FA, Cecchini R. Genistein abrogates pre-hemolytic and oxidative stress damage induced by 2,2′-azobis(amidinopropane). Life Sci 2006; 78:1202–10.10.1016/j.lfs.2005.06.047Search in Google Scholar

45. Rohn TT, Hinds TR, Vincenzi FF. Inhibition of Ca2+ pump ATPase and the Na+/K+ pump ATPase by iron-generated free radicals. Protection by 6,7-dimethyl-2,4-D1-1 pyrrolidinyl-7H-pyrrolo[2,3-d] pyrimidine sulfate (U-89843D), a potent, novel antioxidant/free radical scavenger. Biochem Phamacol 1996; 51:471–6.10.1016/0006-2952(95)02222-8Search in Google Scholar

46. Richards DM, Dean RT, Jessup W. Membrane proteins are critical targets in free radical mediated cytolysis. Biochim Biophys Acta 1988; 946:281–8.10.1016/0005-2736(88)90403-8Search in Google Scholar

47. Maridonneau I, Braquet P, Garay RP. Na+ and K+ transport damage induced by oxygen free radicals in human red blood cell membranes. J Biol Chem 1983; 258:3107–13.10.1016/S0021-9258(18)32837-0Search in Google Scholar

48. Rauchova H, Drahota Z, Koudelova J. The role of membrane fluidity changes and thiobarbituric acid-reactive substances production in the inhibition of cerebral cortex Na+/K+ ATPase Activity. Physiol Res 1999; 48:73–8.Search in Google Scholar

Received: 2005-10-31
Accepted: 2006-2-6
Published Online: 2006-5-8
Published in Print: 2006-5-1

©2006 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. CCLM: Expanding the science worldwide
  2. Factor V Leiden, prothrombin G20210A substitution and hormone therapy: indications for molecular screening
  3. Immunochemical quantification of free immunoglobulin light chains from an analytical perspective
  4. De novo deletion removes a conserved motif in the C-terminus of ABCA4 and results in cone-rod dystrophy
  5. Molecular detection of squamous cell carcinoma antigen transcripts in peripheral blood of cancer patients
  6. Influence of human haptoglobin polymorphism on oxidative stress induced by free hemoglobin on red blood cells
  7. Real-time RT-PCR quantification of PRAME gene expression for monitoring minimal residual disease in acute myeloblastic leukaemia
  8. Association of high-sensitive C-reactive protein with advanced stage β-cell dysfunction and insulin resistance in patients with type 2 diabetes mellitus
  9. A longitudinal evaluation of urinary glycosaminoglycan excretion in normoalbuminuric type 1 diabetic patients
  10. National survey on the execution of the oral glucose tolerance test (OGTT) in a representative cohort of Italian laboratories
  11. The reduction of cholesteryl linoleate in lipoproteins: an index of clinical severity in β-thalassemia/Hb E
  12. Alterations in serum glycosaminoglycan profiles in Graves' patients
  13. Alterations in anti-oxidative defence enzymes in erythrocytes from sporadic amyotrophic lateral sclerosis (SALS) and familial ALS patients
  14. Sandwich ELISAs for soluble immunoglobulin superfamily receptor translocation-associated 2 (IRTA2)/FcRH5 (CD307) proteins in human sera
  15. Utilizing ultrafiltration to remove alkaline phosphatase from clinical analyzer water
  16. Measurement of serum monoclonal components: comparison between densitometry and capillary zone electrophoresis
  17. Salivary aspartate aminotransferase, alanine aminotransferase and alkaline phosphatase: possible markers in periodontal diseases?
  18. Reticulocyte count, mean reticulocyte volume, immature reticulocyte fraction, and mean sphered cell volume in elite athletes: reference values and comparison with the general population
  19. Serum homocysteine levels and paraoxonase 1 activity in preschool aged children in Greece
  20. The effects of adrenocorticotrophic hormone and cortisol on homocysteine and vitamin B concentrations
  21. Plasma, salivary and urinary cotinine in non-smoker Italian women exposed and unexposed to environmental tobacco smoking (SEASD study)
  22. Cut-off values for total serum immunoglobulin E between non-atopic and atopic children in north-west Croatia
  23. Thyroglobulin assay during thyroxine treatment in low-risk differentiated thyroid cancer management: comparison with recombinant human thyrotropin-stimulated assay and imaging procedures
  24. Evaluation of serum levels of p53 in hepatocellular carcinoma in Egypt
  25. Insufficient filling of vacuum tubes as a cause of microhemolysis and elevated serum lactate dehydrogenase levels. Use of a data-mining technique in evaluation of questionable laboratory test results
  26. Evaluation of three different specimen types (serum, plasma lithium heparin and serum gel separator) for analysis of certain analytes: clinical significance of differences in results and efficiency in use
  27. Comparative evaluation of a new immunoradiometric assay for corticotropin
  28. Mast cells in atherosclerosis as a source of the cytokine RANKL
  29. Falsely increased total serum protein due to dextran interference
Downloaded on 13.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2006.095/html
Scroll to top button